Find the right Medicare plan for 2026 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

Why CMS Is Trying to Ban Third-Party Remote Patient Monitoring

CMS’ proposed 2027 Physician Fee Schedule would bar Medicare payment for remote monitoring services delivered by third-party vendors, following OIG reports that flagged widespread fraud in the space. The post Why CMS Is Trying to Ban Third-Party Remote Patient Monitoring appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition

Eli Lilly’s AtaiBeckley acquisition marks a dozen M&A deals for the pharma company so far this year. AtaiBeckley’s lead program is an intranasally administered psychedelic drug in pivotal testing for treatment-resistant depression. The post Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition appeared first on MedCity News .

Read full article →
Medicare News MedCity News

What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook

This is not an argument against capital in independent medicine. Practices need infrastructure, and physicians have legitimate reasons to seek liquidity. It is an argument that the exit stage carries a risk this market has not yet priced. The post What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook appeared first on MedCity News .

Read full article →
Medicare News KFF Health News

A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry

A ballot measure to eliminate Missouri’s income tax would give the state legislature broad authority to levy new sales taxes to replace the lost revenue. Critics say that could mean adding a sales tax on medical services or prescription medicines. Those types of taxes are unusual, but not unheard of, in the U.S.

Read full article →
Medicare News MedCity News

‘The Moat is No Longer Technological’: How Digital Health Fundraising Changed in H1

Digital health funding hit $7.4 billion in the first half of 2026, with megadeals absorbing nearly half of all capital. As AI becomes table stakes, founders and investors say the real differentiator is now domain expertise rather than technology. The post ‘The Moat is No Longer Technological’: How Digital Health Fundraising Changed in H1 appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Celcuity’s First-in-Class Drug Gets FDA Approval in Most Common Type of Breast Cancer

Celcuity drug Revtorpyk is now approved for advanced cases of the most common type of breast cancer that do not harbor a certain mutation. The intravenously infused medicine is first in a new drug class that addresses a pathway associated with many cancers. The post Celcuity’s First-in-Class Drug Gets FDA Approval in Most Common Type of Breast Cancer appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Neko Health Secures $700M to Support US Expansion

Neko’s Series C round was co-led by Lightspeed Venture Partners and O.G. Venture Partners, with participation from Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum and BDT & MSD. The post Neko Health Secures $700M to Support US Expansion appeared first on MedCity News .

Read full article →